Assenagon Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
184,585
-496,968
| -73% | -$706K | ﹤0.01% | 1074 |
|
|
2025
Q1 | $1.04M | Buy |
681,553
+284,191
| +72% | +$435K | ﹤0.01% | 869 |
|
|
2024
Q4 | $985K | Buy |
397,362
+211,585
| +114% | +$525K | ﹤0.01% | 1083 |
|
|
2024
Q3 | $214K | Buy |
+185,777
| New | +$214K | ﹤0.01% | 1285 |
|
|
2023
Q4 | – | Sell |
-687,135
| Closed | -$4.71M | – | 1345 |
|
|
2023
Q3 | $4.71M | Buy |
687,135
+50,306
| +8% | +$345K | 0.01% | 572 |
|
|
2023
Q2 | $6.6M | Buy |
636,829
+211,001
| +50% | +$2.19M | 0.02% | 414 |
|
|
2023
Q1 | $3.44M | Buy |
425,828
+230,905
| +118% | +$1.87M | 0.01% | 656 |
|
|
2022
Q4 | $3.07M | Hold |
194,923
| – | – | 0.01% | 642 |
|
|
2022
Q3 | $3.07M | Sell |
194,923
-98,122
| -33% | -$1.54M | 0.01% | 572 |
|
|
2022
Q2 | $4.09M | Sell |
293,045
-214,390
| -42% | -$2.99M | 0.02% | 582 |
|
|
2022
Q1 | $8.75M | Buy |
+507,435
| New | +$8.75M | 0.02% | 376 |
|
|
2021
Q4 | – | Sell |
-473,365
| Closed | -$8.52M | – | 1366 |
|
|
2021
Q3 | $8.52M | Sell |
473,365
-103,507
| -18% | -$1.86M | 0.03% | 278 |
|
|
2021
Q2 | $10.1M | Buy |
576,872
+556,283
| +2,702% | +$9.77M | 0.03% | 306 |
|
|
2021
Q1 | $519K | Buy |
+20,589
| New | +$519K | ﹤0.01% | 986 |
|
|
2019
Q3 | – | Sell |
-82,905
| Closed | -$182K | – | 774 |
|
|
2019
Q2 | $182K | Buy |
+82,905
| New | +$182K | ﹤0.01% | 916 |
|
|
2019
Q1 | – | Sell |
-121,011
| Closed | -$894K | – | 881 |
|
|
2018
Q4 | $894K | Buy |
+121,011
| New | +$894K | 0.01% | 639 |
|